• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Livongo Health acquires weight-management, disease-prevention dev Retrofit

April 18, 2018 By Fink Densford

Livongo, Retrofit

Livongo Health said yesterday it acquired weight-management and disease-prevention program developer Retrofit for an undisclosed amount.

With the acquisition, Mountain View, Calif.-based Livongo Health said it will make Retrofit’s Diabetes Prevention program available as Livongo DPP, powered by Retrofit. Livongo said the acquisition acts as a compliment to its Livongo for Diabetes and Livongo for Hypertension programs.

“Retrofit has built strong, evidence-based, offerings in weight management and disease prevention and brings a great group of committed people. We’re excited to welcome their team into the Livongo family. For our members, we now have more services that make it easier to prevent individuals from getting sick and, if they do, working with them to return to health and stay healthy. And for our clients, we’re now addressing the comprehensive health challenges their employees face, with the goal of caring for each as a whole person,” Livongo CEO Glen Tullman said in a prepared statement.

Livongo said it will also make use of Retrofit’s over seven years of data insights, coaches and proprietary lifestyle factor segmentation to improve its personalized offerings. Retrofit CEO Mary Pigatti will join Livongo as part of the acquisition, and will remain at the head of Retrofit.

“Retrofit and Livongo are like-minded in strategy, values and culture. Together, we will provide a comprehensive set of solutions for the prevention and treatment of chronic conditions that address the whole person. This move strengthens our ability to bring personalized solutions to our clients and members,” Retrofit CEO Pigatti said in a press release.

Last week, Livongo closed a $105 million round led by a group of investors including General Catalyst, Merck Global Health Innovation Fund and Echo Health Ventures.

Filed Under: Diabetes, Featured, Technology Tagged With: livongohealth, retrofit

IN CASE YOU MISSED IT

  • Abbott could pave new roads in diabetes management with dual sensor on the horizon
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS